For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Waters Corporation (WAT) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Waters Corporation is a scientific instrumentation company that provides analytical workflow solutions to customers in the life sciences, industrial, and academic sectors. The company specializes in liquid chromatography systems, mass spectrometry platforms, and related precision chemistry consumables that support complex chemical and biochemical analysis. Through its Waters segment, it delivers integrated instruments, software, and services used in drug development, quality control, food and environmental testing, and advanced materials research. Its TA Instruments segment focuses on thermal analysis and rheology equipment that measure material properties such as stability, viscosity, and mechanical performance for industrial and research applications. Waters Corporation serves biopharmaceutical companies, industrial manufacturers, and government and academic laboratories globally, with a particularly strong presence in diagnostics and research-related workflows. Founded in 1958 and headquartered in Milford, Massachusetts, Waters Corporation plays a significant role in enabling precise measurement, regulatory compliance support, and data-driven decision-making across regulated and research-intensive markets.
Earnings Schedule
Checked daily · calendar updated Aug 9| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | $3.01 | $3.05 +1.3% | — | — |
| May 20, 2026 | $2.91 | $3.09 +6.2% | — | — |
| May 5, 2026 | $2.31 | $2.70 +16.9% | — | — |
| Feb 9, 2026 | $4.51 | $4.53 +0.4% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Recent SEC Filings
| Filed | Form | Document |
|---|---|---|
| Aug 7, 2026 | 4 | View |
| Aug 6, 2026 | 144 | View |
| Aug 4, 2026 | 8-K | View |
| Jul 2, 2026 | 4 | View |
| Jul 2, 2026 | 4 | View |
| Jun 25, 2026 | 4 | View |
| Jun 25, 2026 | 11-K | View |
| May 29, 2026 | SD | View |
| May 22, 2026 | 8-K | View |
| May 15, 2026 | SCHEDULE 13G/A | View |
| May 14, 2026 | 4 | View |
| May 12, 2026 | 10-Q | View |
Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.
Price Overview
Last updated: Aug 9, 2026 3:19am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 10.76
Total Equity: $2.56B
Shares: 59,706,000
Total Debt: $947.45M
Cash: $587.83M
EBITDA: $890.73M
Total Debt: $947.45M
Cash: $587.83M
Revenue: $3.17B
Revenue: $3.17B
Revenue: $3.17B
Total Equity: $2.56B
Tax Rate: 14.9%
Equity: $2.56B
Total Debt: $947.45M
Cash: $587.83M
Current Liabilities: $1.24B
Long-Term Debt: $947.45M
Total Debt: $947.45M
Total Equity: $2.56B
Shares: 59,706,000
Shares: 59,706,000
CapEx: -$112.75M
Shares: 59,706,000
Stock Price: $406.86
Net Income: $642.63M
Income Statement (Annual)
Last updated: Aug 6, 2026 6:17pm (2d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.8B | $3.0B | $3.0B | $3.0B | $3.2B |
| Cost of Revenue | $1.2B | $1.2B | $1.2B | $1.2B | $1.3B |
| Gross Profit | $1.6B | $1.7B | $1.8B | $1.8B | $1.9B |
| Operating Expenses | $807.6M | $850.4M | $943.5M | $931.8M | $1.1B |
| Operating Income | $821.7M | $873.4M | $817.7M | $826.4M | $802.6M |
| Net Income | — | $707.8M | $642.2M | $637.8M | $642.6M |
| EBITDA | $893.3M | $945.4M | $902.3M | $913.4M | $890.7M |
| EPS | $11.25 | $11.80 | $10.87 | $10.75 | $10.80 |
| EPS (Diluted) | $11.17 | $11.73 | $10.84 | $10.71 | $10.76 |
Balance Sheet (Annual)
Last updated: Aug 6, 2026 6:17pm (2d ago)| Metric | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $480.5M | — | $395.1M | $324.4M | $587.8M |
| Total Current Assets | $1.8B | — | $1.8B | $1.7B | $2.1B |
| Total Assets | $3.3B | — | $4.6B | $4.6B | $5.1B |
| Current Liabilities | $785.7M | — | $789.6M | $789.8M | $1.2B |
| Long-Term Debt | $1.5B | — | $2.3B | $1.6B | $947.4M |
| Total Liabilities | $2.8B | — | $3.5B | $2.7B | $2.5B |
| Total Equity | $504.5M | — | $1.2B | $1.8B | $2.6B |
| Retained Earnings | $8.5B | — | $9.2B | $9.8B | $10.4B |
Cash Flow (Annual)
Last updated: Aug 6, 2026 6:17pm (2d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $747.3M | $611.7M | $602.8M | $762.1M | $652.6M |
| Capital Expenditure | — | — | -$160.6M | -$142.5M | -$112.7M |
| Free Cash Flow | — | — | $442.2M | $619.6M | $539.8M |
| Acquisitions (net) | $0 | $0 | -$1.3B | $0 | -$35.1M |
| Net Debt Issued / (Repaid) | $160.0M | $60.0M | $780.0M | -$730.0M | -$220.0M |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$648.9M | -$626.1M | -$70.3M | -$13.5M | -$14.7M |
| Net Change in Cash | $64.5M | -$20.7M | -$85.5M | -$70.7M | $262.5M |
Growth Trends (YoY %)
Last updated: Aug 6, 2026 6:17pm (2d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +6.7% | -0.5% | +0.1% | +7.0% |
| Gross Profit Growth | +5.8% | +2.2% | -0.2% | +6.7% |
| Operating Income Growth | +6.3% | -6.4% | +1.1% | -2.9% |
| Net Income Growth | — | -9.3% | -0.7% | +0.8% |
| EBITDA Growth | +5.8% | -4.6% | +1.2% | -2.5% |
Dividend History (Last 20)
Last updated: Aug 2, 2026 9:17pm (6d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 1996-11-26 | $0.01 | — | — | — |
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Narrative Economics
market-narrative step).
Claude Reading
ai-findings step) when a report is run on this ticker.
GPT Reading
gpt-critique step) after the other Big-3 seats, when a
report is run on this ticker.
Grok Reading
grok-critique step) alongside the other Big-3 seats, when a
report is run on this ticker.
Advanced Analysis Forensic deep-dive · three lenses
Character & Durability Scorecard
ext-scorecard step) when a report is run on this ticker.